A multi-stakeholder approach in optimising patients’ needs in the benefit assessment process of new metastatic breast cancer treatments()

There is a growing understanding as science evolves that different cancer types require different approaches to treatment evaluation, especially in the metastatic stages. The introduction of new metastatic breast cancer (MBC) treatments may be hindered by several elements, including the availability...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardoso, Fatima, Wilking, Nils, Bernardini, Renato, Biganzoli, Laura, Espin, Jaime, Miikkulainen, Kaisa, Schuurman, Susanne, Spence, Danielle, Spitz, Sabine, Ujupan, Sonia, Zernik, Nicole, Gordon, Jenn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487948/
https://www.ncbi.nlm.nih.gov/pubmed/32450470
http://dx.doi.org/10.1016/j.breast.2020.04.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487948/
https://www.ncbi.nlm.nih.gov/pubmed/32450470
http://dx.doi.org/10.1016/j.breast.2020.04.011

Ejemplares similares